Page 140 - Health Medical Pharma
Californian shrub may hold key to treating Alzheimer's
A shrub, used by native Californian tribes to treat respiratory ailments, fever and headaches, contains a potent chemical which could help treat Alzheimer's disease, a study claims. The medicinal powers of aspirin, digitalis, and the anti-malarial artemisinin all come from plants. The research, published in the journal Redox Biology, shows a that the treatment for Alzheimer's disease may also be found in nature. "Because age is a major risk factor, researchers are looking at ways to counter aging's effects on the brain," said Pamela Maher, a scientist at Salk Institute in the US. "Our identification of sterubin as a potent neuroprotective component of a native California plant called Yerba santa (Eriodictyon californicum) is a promising step in that direction," Maher said. Native California tribes, which dubbed the plant "holy herb" in Spanish, have long used Yerba santa for its medicinal properties. Devotees brew its leaves to treat respiratory ailments, fever and headaches; and mash
Medicinal plant Yerba santa may hold promise for treating Alzheimer's
A new discovery that found neuroprotective and anti-inflammatory chemical in a native California shrub may lead to a treatment for Alzheimer's disease based on a compound found in nature. The research appeared in the journal Redox Biology.Speaking about it, study author Pamela Maher said, "Alzheimer's disease is a leading cause of death in the United States," adding, "And because age is a major risk factor, researchers are looking at ways to counter aging's effects on the brain. Our identification of sterubin as a potent neuroprotective component of a native California plant called Yerba santa (Eriodictyon californicum) is a promising step in that direction."Native California tribes, which dubbed the plant "holy herb" in Spanish, have long used Yerba santa for its medicinal properties. Devotees brew its leaves to treat respiratory ailments, fever and headaches; and mash it into a poultice for wounds, sore muscles and rheumatism.The researchers applied a screening technique used in ...
Here's how genes affect tobacco and alcohol use
A recent study now has discovered several genes associated with an increased use of alcohol and tobacco.Notably, the use of alcohol and tobacco is closely linked to several diseases, and is a contributing factor in many deaths.The study, published in the journal Nature Genetics saw involvement of everal research groups around the world, including a group from the Nord-Trøndelag Health Study (HUNT) and the K.G. Jebsen Center for Genetic Epidemiology.Speaking about it, co author Professor Kristian Hveem, "We discovered several genes associated with an increased use of alcohol and tobacco. We also looked at the correlation between these genes and the risk of developing various diseases and disorders."The research groups discovered a total of 566 gene variants at 406 different sites in the human genetic material that can be linked to the use of alcohol or tobacco. One hundred fifty of these sites are linked to the use of both tobacco and alcohol.Alcohol consumption was measured in terms ..
New robot sensor can diagnose reproductive problems in real-time
Scientists have developed a new robotic sensor technology that can be used to measure hormones which affect fertility, sexual development and menstruation more quickly and cheaply than current methods. The technology, described in the journal Nature Communications, was tested in patients at Hammersmith Hospital in the UK. Doctors usually diagnose severe reproductive health problems such as infertility and early menopause by carrying out a blood test to measure the amount of luteinising hormone (LH) in the sample, said researchers at Imperial College London in the UK and The University of Hong Kong. Current blood tests cannot easily measure the rise and fall of LH levels which is vital for normal fertility -- so-called LH pulse patterns that are linked to reproductive disorders. It is not currently feasible to measure LH pulse patterns in a clinical setting as doctors need to take a blood sample from patients every 10 minutes for at least eight hours. In addition, the analysis of these
This California plant may hold promise for treating Alzheimer's
A potent neuroprotective and anti-inflammatory chemical in a native California shrub may lead to treatment for Alzheimer's disease, say researchers.
Hooch tragedy survivors suffer blindness
Life will never be the same for Mange Ram (38) of Balupur village in Haridwar, a survivor of the hooch tragedy that claimed more than 100 lives in Uttarakhand and Uttar Pradesh.
Zydus receives USFDA nod for 2 products
Drug firm Zydus Cadila Thursday said it has received approvals from the US health regulator for its Phytonadione tablets and Colchicine tablets. The company has received final approval from the United States Food and Drug Adminstration (USFDA) to market generic Phytonadione tablets USP in the strength of 5 mg, Zydus Cadila said in a statement. The product is used to treat and prevent low levels of blood clotting factors that the body naturally produces when caused by vitamin K deficiency or interference with vitamin K activity, it added. The group also received the final approval for generic Colchicine tablets USP, 0.6 mg, Zydus Cadila said The product is used to prevent or treat attacks of gout, it added. "Both the products will be manufactured at the group's formulations manufacturing facility at SEZ, Ahmedabad," Zydus Cadila said. The group now has 250 approvals and has so far filed over 350 abbreviated new drug applications (ANDAs) since the commencement of its filing process, it .
AstraZeneca joins hands with Nasscom to set up accelerator programme in healthcare
Global biopharmaceutical major AstraZeneca and IT industry body Nasscom Thursday joined hands to set up an accelerator programme to support Indian start-ups in healthcare. At the India-Sweden Unnati Healthcare 2.0 day event here, AstraZeneca and its partners, Business Sweden, Nasscom, Atal Innovation Mission-Niti Aayog and AGNIi also announced the finalists of the Unnati Healthcare Innovation Challenge. The selected winners among the finalists will receive mentorship support from AstraZeneca, which will contribute its unique healthcare domain expertise with the aim of helping the finalists bring their solutions to market. AstraZeneca has launched a strategic partnership with the Nasscom IoT Centre of Excellence to set up an accelerator programme to support Indian start-ups develop new innovative solutions to non-communicable diseases (NCDs) care in India. Under this collaboration, AstraZeneca and Nasscom will incubate start-ups in bringing innovative and frugal solutions that can help
Singing, gardening in middle age may lower dementia risk: Study
Keeping physically and mentally active in middle age may lower the risk of developing dementia decades later, a study claims. Mental activities included reading, playing instruments, singing in a choir, visiting concerts, gardening, doing needlework or attending religious services, according to the study published in the journal Neurology. "These results indicate that these activities in middle age may play a role in preventing dementia in old age and preserving cognitive health," said Jenna Najar from the University of Gothenburg in Sweden. "It's exciting as these are activities that people can incorporate into their lives pretty easily and without a lot of expense," Najar said in a statement. The study involved 800 Swedish women with an average age of 47 who were followed for 44 years. At the beginning of the study, participants were asked about their mental and physical activities. Participants were given scores in each of the five areas based on how often they participated in ...
Zydus Cadila receives USFDA approval for Colchicine Tablets
Powered by Capital Market - Live News
Zydus Cadila receives USFDA approval for Phytonadione Tablets
Powered by Capital Market - Live News
'Origami' paper device offers low-cost malaria diagnosis
Scientists have developed a simple and affordable origami-style paper device that can accurately and quickly detect diseases such as malaria in the remote parts of the developing world. A study, published in the journal Proceedings of the National Academy of Sciences, describes for the first time how folded wax paper, prepared with a printer and a hot plate, has helped detect malaria with 98 per cent sensitivity in infected participants from two primary schools in Uganda. Malaria is one of the world's leading causes of illness and death, affecting more than 219 million people in 90 countries around the globe, and killing 435,000 people in 2017 alone, said researchers from the University of Glasgow in the UK and Shanghai Jiao Tong University in China. A significant issue for arresting and reversing the spread of the disease is diagnosing it in people who are infected but who do not display any symptoms, a problem which can only be addressed by widespread field tests. However, current .
Santokba Durlabhji Memorial Hospital (SDMH) Partners With Medvarsity for Training Medical Professionals
/ -- Partnership to upskill healthcare practitioners with critical care courses Santokba Durlabhji Memorial Hospital (SDMH) partners with Medvarsity Online Ltd., a leader in online medical training for courses related to Emergency medicine, Cardiology, Critical Care & Endocrinology to the practitioners at SDMH, Jaipur, Rajasthan. Each program has been designed thoughtfully to upskill the students to become highly qualified, informed and confident for their healthy professional growth. These set of courses are being deployed at SDMH with a vision to enable and strengthen the present of healthcare practitioners in order to provide better patient care for future. India is facing a lack of upskilled professionals in today's healthcare ecosystem, where 61% of India's higher education leaders believe that our education system is not at par with the society's changing needs, reveals a research conducted by IBM. This is exactly the reason why the country needs to take proactive measures .
Dr Reddy's re-launches generic version of Suboxone in US
: Dr Reddy's Laboratories Ltd. has said it re-launched its Buprenorphine and Naloxone Sublingual Film, generic version of Suboxone in the US market. According to a press release issued by the city-based drug maker Wednesdaynight, the re-launch comes on the heels of a favourable decision delivered by the US Court of Appeals for the Federal Circuitconcluding that UK-based Indivior had not shown that it is likely to succeed on its claim that Dr Reddy's product infringes a patent pertaining to Suboxone. Indivior is in a legal battle against the launch of the copycat version of its opioid addiction treatment by competitors including Dr Reddy's Laboratories in the US market. Suboxone had sales of aroundUSD 1.86 billion in the US for the 12 months ended April2018, according to market reports. "We are pleased with the decision of the appellate court in Dr Reddy's favour, vacating the preliminary injunction that had prevented Dr Reddy's from continuing to market this important ..
Dr. Reddys re-launches Buprenorphine and Naloxone Sublingual Film
The re-launch comes on the heels of a favorable decision issued by the United States Court of Appeals for the Federal Circuit concluding that lndivior had not shown that it is likely to succeed on its claim that Dr. Reddy's product infringes U.S. Patent No. 9,931,305. The Federal Circuit's decision vacates the District Court's preliminary injunction that had prohibited Dr. Reddy's from selling its generic version of Suboxone (buprenorphine and naloxone) sublingual film. The Federal Circuit's decision went into effective yesterday. As a result of the Federal Circuit's ruling, Dr. Reddy's has resumed shipping of the product.
Dr Reddy's Labs gains after re-launch of generic Suboxone film in US
Dr Reddy's Laboratories rose 0.54% to Rs 2,537.25 at 09:19 IST on BSE after the company announced the re-launch of a therapeutic equivalent generic version of Suboxone sublingual film, in the United States market.
TN: Parents accuse Govt hospital of transfusing HIV positive blood to child, hospital denies
Parents of a two-year-old baby have alleged that HIV positive blood was transfused into her at a government hospital in Coimbatore city of Tamil Nadu, while hospital authorities have refuted the claim.According to the parents' accusation, the infected blood was transfused into the baby while she was being treated at the hospital last year.Speaking to ANI, the child's father said, "She was admitted in this hospital last July and was later discharged after transfusion. She developed complications and later tests showed her to be HIV positive".The hospital has however denied the accusation and said that it is prepared for any inquiry.Dr Asokan, Dean, Coimbatore Government Medical College Hospital told ANI, "We dismiss the allegations. She could have been HIV infected after treatment at some other hospital. We have given all medical records related to her. We expect state government officials to come for inquiry. We are ready."Meanwhile, Coimbatore Human Rights Forum (CHRF), which ...
Dr Reddy's re-launch generic version of Suboxone in US
With US Supreme Court ruling in its favour, Indian pharma major Dr. Reddy's Laboratories on Wednesday announced re-launch of generic version of Suboxone, a sublingual film for opioid addition treatment, in the US market.
Dr Reddy's re-launches Buprenorphine and Naloxone Sublingual Film in US mkt
Dr Reddy's Laboratories Wednesday announced the re-launch of its Buprenorphine and Naloxone Sublingual Film in the US market after a favourable court ruling. Buprenorphine and Naloxone Sublingual Film, 2 mg/0.5 mg, 4 mg/1 mg, 8 mg/2 mg, and 12 mg/3 mg, is a therapeutic equivalent generic version of Suboxone (buprenorphine and naloxone) sublingual film, Dr Reddy's said in a BSE filing. The re-launch comes on the heels of a favorable ruling in a patent litigation by the United States Court of Appeals for the Federal Circuit. "We are pleased with the decision of the appellate court in Dr. Reddy's favour, vacating the preliminary injunction that had prevented Dr. Reddy's from continuing to market this important drug to the public," said Marc Kikuchi, Chief Executive Officer, North America Generics. "Dr. Reddy's is committed to providing affordable treatment options for opioid use disorder and addiction. We look forward to helping patients and our communities in the United States who are ..
New AI software can help in early detection of deadly tumours
Despite the advancement in medicine, detection of tumours continues to be challenging with a wide life threatening gap between diagnosis and curability.As science and technology increasingly blur their boundaries, a San Francisco based company called Arterys has received a FDA clearance to market a first-of-its-kind, AI as-a-service software to help doctors detect, measure, and track tumours and lesions in CT scans of lungs and in MRI and CT scans of the liver, Fast Company reported.The software builds upon another artificially intelligent platform called Cardio AI that automates image-analysis tasks which radiologists currently execute manually. By automating, the evaluation time is cut down from 30 minutes to a mere 15 seconds.Arterys software for lungs and liver is expected to bring the same level of efficiency in analysing scans. The company is also looking at including breast scan compatibility to the software.The clearance, received last February, is now allowing the software to